SEC ownership of Scilex Holding Co

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001820190.

Comparable stake leader

SCLX Stock Acquisition JV LLC

Disclosed value leader

SCLX Stock Acquisition JV LLC

Comparable rows

2/50

Latest evidence

03 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
SCLX Stock Acquisition JV LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
03 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001820190
Issuer location
Palo Alto, CA

Ownership snapshot

Top shareholders of Scilex Holding Co (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SCLX Stock Acquisition JV...
Disclosed value leader
SCLX Stock Acquisition JV...
Comparable rows
2/50
Latest evidence
03 Jul 2026
13D/G 3/4/5 13F Lead comparable stake: 11% 48 rows are not safely comparable across share classes. 13D/G row: SCLX Stock Acquisition JV LLC Showing 1-8 of 50 holder rows.

Quick read

SCLX Stock Acquisition JV LLC leads the comparable SEC ownership view at 11%.

2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SCLX Stock Acquisition JV LLC's linked filing trail.
Comparable ownership Top 2
SCLX Stock Acquisition JV LLC 11%
ORAMED PHARMACEUTICALS INC. 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SCLX Stock Acquisition JV LLC
13D/G 3/4/5
10%+ Owner
11%
Reported 13D/G · 03 Jul 2026
$234,280,198
30,029,378 shares
$0 03 Jul 2026
ORAMED PHARMACEUTICALS INC.
13D/G
4.9%
Reported 13D/G · 31 Dec 2025
$5,438,249
437,510 shares
-$4,921,820 31 Dec 2025
Scilex Holding Co
3/4/5
10%+ Owner
—
denominator unverified
$131,853,773
244,445,260 shares
-$10,001,498 26 Dec 2025
Sorrento Therapeutics, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$1,687,145
1,917,210 shares
— 21 Sep 2023
Vickers Venture Fund VI Pte Ltd
3/4/5
Other*, 10%+ Owner
—
denominator unverified
—
1,000,000 shares
— 10 Nov 2022
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$2,350,078
301,292 shares
— 30 Jun 2026
Henry Ji
3/4/5
Exec Chair, CEO and President, Director
—
mixed-class rows
$983,196
3,340,814 shares
mixed-class rows
+$399,880 16 Apr 2026
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$853,453
109,417 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$9,501,648.

Buys
$599,820
Insiders: 2
Sells
$10,101,468
Insiders: 2
Net
-$9,501,648
Shares: -13,718,284
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 3,900,000 Shares: 17,618,284
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 3,900,000 650,000 $599,820 $99,970 +$499,850
9-12 0 16,968,284 $0 $10,001,498 -$10,001,498

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to Scilex Holding Co. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
Scilex Holding Co
Net 12M change
-$9,501,648
Latest report
03 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Scilex Holding Co 10%+ Owner $131,853,773 -$10,001,498 -7.1% Filing P/S 26 Dec 2025
SCLX Stock Acquisition JV LLC 10%+ Owner $7,476,080 Mixed 03 Jul 2026
Sorrento Therapeutics, Inc. 10%+ Owner $1,687,145 Mixed 21 Sep 2023
Henry Ji Exec Chair, CEO and President, Director $983,196 +$399,880 +69% Mixed 16 Apr 2026
Jaisim Shah Chief Executive Officer and President, Director $135,799 Mixed 18 Dec 2024
Stephen Hoi Ma CFO, COO and Secretary, Director $122,125 +$99,970 +451% Filing P/S 17 Apr 2026
Jay Chun Director $106,885 Mixed 08 Oct 2025
Yue Alexander Wu Director $23,740 Filing P/S 08 Oct 2025
Dorman Followwill Director $2,277 Filing P/S 08 Oct 2025
David Lemus Director $1,800 Filing P/S 17 Oct 2024
Annu Navani Director Mixed 16 Aug 2024
Tommy G. Thompson Director Mixed 17 Jan 2023
Elizabeth Czerepak Executive Vice President, Chief Business Officer and Chief Financial Officer Mixed 17 Jan 2023
Tien-Li Lee Director Mixed 17 Jan 2023
Laura Jean Hamill Director Mixed 17 Jan 2023
Vickers Venture Fund VI Pte Ltd Other*, 10%+ Owner Mixed 10 Nov 2022
Pei Wei Woo Director, Effective November 10, 2022, Pei Wei Woo is no longer a Director of Vickers Vantage Corp. I Mixed 10 Nov 2022
Suneel G. Kaji Director, Effective November 10, 2022, Suneel G. Kaji is no longer a Director of Vickers Vantage Corp. I Mixed 10 Nov 2022
Steve Myint Director, Effective November 10, 2022, Steve Myint is no longer a Director of Vickers Vantage Corp. I Mixed 10 Nov 2022

Recent insider transactions for Scilex Holding Co

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
SCLX Stock Acquisition JV LLC SCLX Common stock Other -34.3% -500,000 958,263 03 Jul 2026 Direct
Stephen Hoi Ma SCLX Warrant (right to buy) Purchase $99,970 $0.1538 650,000 650,000 17 Apr 2026 Direct
Henry Ji SCLX Warrant (right to buy) Sale -20% $99,970 $0.1538 -650,000 2,600,000 17 Apr 2026 Direct
Henry Ji SCLX Warrant (right to buy) Purchase $499,850 $0.1538 3,250,000 3,250,000 16 Apr 2026 Direct
Scilex Holding Co SCLX Common Stock Sale -3.8% $5,209,148 $0.5394 -9,657,300 244,445,260 30 Dec 2025 Direct
Scilex Holding Co SCLX Common Stock Sale -2.8% $4,792,350 $0.6555 -7,310,984 254,102,560 29 Dec 2025 Direct
Scilex Holding Co SCLX Common Stock Sale -1.39% -3,689,016 261,413,544 26 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .